Weight-loss drug companies are scrambling to make more
Shortages of weight-loss drugs are driving pharmaceutical companies to scramble to shore up supplies. Why it matters: Booming demand for anti-obesity drugs, known as GLP-1s, has led to a windfall of revenue for pharma giants like Novo Nordisk and Eli Lilly. Driving the news: Novo Nordisk parent…
#glp1s #novonordisk #elililly #novoholdings #catalent #belgium #wegovyandozempic #lilly #zepbound #glp1
